Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis

被引:1282
作者
Wetterslev, Jorn [1 ]
Thorlund, Kristian [1 ]
Brok, Jesper [1 ]
Gluud, Christian [1 ]
机构
[1] Univ Copenhagen Hosp, Rigshosp, Ctr Clin Interven Res, Copenhagen Trial Unit,Dept 3344, DK-2100 Copenhagen, Denmark
关键词
meta-analysis; cumulative meta-analysis; trial sequential monitoring boundaries; type I error; type II error; heterogeneity; information size; sample size;
D O I
10.1016/j.jclinepi.2007.03.013
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background and Objective: Cumulative meta-analyses are prone to produce spurious P < 0.05 because of repeated testing of significance as trial data accumulate. Information size in a meta-analysis should at least equal the sample size of an adequately powered trial. Trial sequential analysis (TSA) corresponds to group sequential analysis of a single trial and may be applied to meta-analysis to evaluate the evidence. Study Design and Setting: Six randomly selected neonatal meta-analyses with at least five trials reporting a binary outcome were examined. Low-bias heterogeneity-adjusted information size and information size determined from an assumed intervention effect of 15% were calculated. These were used for constructing trial sequential monitoring boundaries. We assessed the cumulative z-curves' crossing of P = 0.05 and the boundaries. Results: Five meta-analyses showed early potentially spurious P < 0.05 values. In three significant meta-analyses the cumulative z-curves crossed both boundaries, establishing firm evidence of an intervention effect. In two nonsignificant meta-analyses the cumulative z-curves crossed P = 0.05, but never the boundaries, demonstrating early potentially spurious P < 0.05 values. In one nonsignificant meta-analysis the cumulative z-curves never crossed P = 0.05 or the boundaries. Conclusion: TSAs may establish when firm evidence is reached in meta-analysis. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:64 / 75
页数:12
相关论文
共 46 条
[1]  
ALSNIELSEN B, 2004, 12 INT COCHR C OTT, P88
[2]   Meta-analysis, Simpson's paradox, and the number needed to treat [J].
Altman D.G. ;
Deeks J.J. .
BMC Medical Research Methodology, 2 (1) :1-5
[3]  
[Anonymous], 12 COCHR C BRIDG GAP
[4]   SEQUENTIAL ANALYSIS IN THERAPEUTIC TRIALS [J].
ARMITAGE, P .
ANNUAL REVIEW OF MEDICINE, 1969, 20 :425-+
[5]  
BARRINGTON KJ, 2000, COCHRANE DB SYST REV, V2
[6]   Uncertainty of the time of first significance in random effects cumulative meta-analysis [J].
Berkey, CS ;
Mosteller, F ;
Lau, J ;
Antman, EM .
CONTROLLED CLINICAL TRIALS, 1996, 17 (05) :357-371
[7]   Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis [J].
Bjelakovic, G ;
Nikolova, D ;
Simonetti, RG ;
Gluud, C .
LANCET, 2004, 364 (9441) :1219-1228
[8]   Mortality in randomized trials of antioxidant supplements for primary and secondary prevention - Systematic review and meta-analysis [J].
Bjelakovic, Goran ;
Nikolova, Dimitrinka ;
Gluud, Lise Lotte ;
Simonetti, Rosa G. ;
Gluud, Christian .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (08) :842-857
[9]  
BRION LP, 2003, COCHRANE DB SYST REV, V4
[10]  
BROK J, 2006, CLIN TRIALS, V3, P241